InsidersTradesSigma
Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Browse the complete record of transactions filed by Hopman Mark. Officer active across 1 company, notably Beta Bionics, Inc.. In total, 11 reports have been recorded. Split: 0 buy · 7 sells. Total volume traded: €103k. History available since 27 February 2025. The latest transaction was filed on 4 June 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 de 11 declaraciones
Hopman Mark is a declarant with 11 filings in total. Across the 11 sampled filings, which run from 2025-03-03 to 2026-06-25, the filings show disposals of EUR 103196, with Beta Bionics, Inc. as the company mentioned; the listed role for that company is Chief Commercial Officer.